BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ingredientpharm - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ingredientpharm.com
X-WR-CALDESC:Events for Ingredientpharm
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261020
DTEND;VALUE=DATE:20261023
DTSTAMP:20260112T144133Z
CREATED:20260112T144133Z
LAST-MODIFIED:20260112T144133Z
UID:2373-1792454400-1792713599@ingredientpharm.com
SUMMARY:24th Pharma Asia
DESCRIPTION:The Pharma Asia International Exhibition and Conferences serves as Pakistan’s premier pharmaceutical machinery and technology trade show. Pharma Asia event is attracting significant global attention. This flagship event consistently ranks as the largest industry gathering in Pakistan. Manufacturers\, innovators\, and decision‑makers across pharmaceutical manufacturing and allied sectors connect. The 23rd edition ran from October 20-22\, 2026\, at the Expo Centre in Karachi\, drawing unprecedented participation and business engagement. \nOrganized by Pharma Asia International Exhibition & Conferences\, the exhibition showcased advanced pharma technologies\, machinery\, and digital solutions. The agenda highlighted industry transformation through modernization\, digitalization\, and regulatory engagement. \nThe event featured more than 750 exhibition stalls and over 200 international exhibitors representing at least 10 countries. Prominent global participation from China\, Italy\, Turkey\, Switzerland\, and Spain. China hosted the largest international pavilion\, underscoring strong multinational interest in Pakistan’s pharmaceutical market. \nReview: Pharma Asia 2025 attracted over 27\,000 pharmaceutical professionals\, including manufacturers\, exporters\, pharmacists\, researchers\, regulatory officials\, and foreign delegates eager to engage with cutting‑edge technologies and forge partnerships. The visitor profile ranged from industry executives and trade corporate visitors to academic stakeholders and commercial attaches. \nKey topics at the exhibition spanned \n\npharmaceutical machinery\,\npackaging solutions\,\nquality control systems\,\nlaboratory equipment\,\nraw materials.\n\nExpert‑led sessions emphasized industry digitization\, technology transfer\, and export expansion strategies\, reflecting the sector’s ambition to reach a USD 10 billion export target. \nOutstanding opportunities emerged in technology acquisition\, joint ventures\, and market expansion across South Asia\, the Middle East\, and Central Asia. Exhibitors and attendees identified strong prospects for investment facilitation\, capacity building\, and strategic partnerships with local and foreign stakeholders. \nOverall\, Pharma Asia remains a catalyst for growth in pharmaceutical machinery and technology\, offering a focused environment for networking\, business development\, and innovation in one of South Asia’s fastest‑growing healthcare markets.
URL:https://ingredientpharm.com/event/24th-pharma-asia/
LOCATION:Karachi Expo Centre\, Main Main University Rd\, Block 15 Gulshan-e-Iqbal\, Karachi\, Pakistan\, Pakistan
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2026/01/24th-Pharma-Asia-2026.jpg
ORGANIZER;CN="Pharma Asia International Exhibition & Conferences":MAILTO:info@pharmaasia.com.pk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261020
DTEND;VALUE=DATE:20261022
DTSTAMP:20260112T144129Z
CREATED:20260112T144129Z
LAST-MODIFIED:20260112T144129Z
UID:2218-1792454400-1792627199@ingredientpharm.com
SUMMARY:World Vaccine Congress Europe 2026
DESCRIPTION:The World Vaccine Congress Europe 2026 is a premier global event focused on vaccines\, immunotherapy\, and infectious disease research in Europe. Importantly\, it convenes leaders from pharmaceuticals\, biotechnology\, academia\, regulators\, and public health organizations. Together\, they share knowledge\, explore innovations\, and discuss strategies for vaccine development\, manufacturing\, and distribution. As a result\, the congress is recognized as one of the world’s leading vaccine-focused events. Consequently\, it serves as a strategic platform for scientific exchange\, collaboration\, and business development. \nIn 2026\, the congress will address key topics shaping the vaccine landscape. Specifically\, these include novel technologies\, mRNA and viral vector platforms\, adjuvants\, and immuno-oncology vaccines. In addition\, sessions will cover clinical development strategies\, regulatory frameworks\, pandemic preparedness\, and large-scale manufacturing solutions. Furthermore\, discussions will explore global health initiatives\, AI-driven research\, advanced analytics\, and supply-chain resilience. Overall\, these themes highlight the intersection of innovation\, policy\, and practical vaccine delivery. \nTypically\, attendees include vaccine developers\, pharmaceutical and biotech executives\, and clinical researchers. Moreover\, immunologists\, regulatory experts\, policy leaders\, public health officials\, and investors are well represented. As a result\, participants can network\, form collaborations\, and gain insights into emerging trends and regulatory expectations. Notably\, these insights span both European and global markets. \nFinally\, the congress offers strong opportunities to showcase technologies and explore partnership or licensing opportunities. Additionally\, companies gain direct access to key decision-makers across the vaccine ecosystem. Key industries represented include biotechnology\, pharmaceutical manufacturing\, CROs\, diagnostics\, and public health organizations. By uniting the full stakeholder spectrum\, the 2026 congress aims to accelerate innovation and strengthen global vaccination strategies.
URL:https://ingredientpharm.com/event/world-vaccine-congress-europe-2026/
LOCATION:Amsterdam RAI\, Europaplein 24\, Amsterdam\, 1078 GZ\, Netherlands
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/World-Vaccine-Congress-Europe-2026.jpg
ORGANIZER;CN="Terrapinn Holdings Ltd":MAILTO:enquiry.uk@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261006
DTEND;VALUE=DATE:20261009
DTSTAMP:20260112T144112Z
CREATED:20260112T144112Z
LAST-MODIFIED:20260112T144112Z
UID:2273-1791244800-1791503999@ingredientpharm.com
SUMMARY:CPhI Europe 2026
DESCRIPTION:CPhI Europe 2026 will take place from 6–8 October 2026 at Fiera Milano in Milan\, Italy. Organized by Informa Markets\, the event will unite global pharmaceutical supply-chain players under one roof. \nScope & Core Topics\nCPhI covers the entire pharmaceutical value chain—from raw materials to final formulations. It includes active pharmaceutical ingredients (APIs)\, excipients\, fine chemicals\, natural extracts\, and finished dosage forms.Moreover\, the fair features biopharma\, contract manufacturing and development services (CDMO/CRO)\, drug-delivery systems\, packaging innovations\, and machinery & equipment for production and processing.For 2026\, CPhI expands with new zones: an AI & Tech zone\, Cleanroom solutions\, Cold-chain & Pharma Logistics\, and Labelling & packaging tech. This reflects the pharma sector’s growing demand for digital tools\, compliance\, and supply-chain robustness. \nWho Attends: Key Visitors & Participants\nCPhI draws a wide range of industry stakeholders. These include pharmaceutical manufacturers\, API and excipient suppliers\, biotech and biopharma companies\, and contract manufacturers.Also present are R&D specialists\, regulatory and quality-assurance teams\, procurement officers\, packaging and drug-delivery vendors\, and machinery or lab-equipment providers.Additionally\, experts in digital pharma solutions\, logistic services\, and cold-chain management will attend — especially to explore the new AI & Tech and logistics zones. \nOutstanding Opportunities\nBy attending CPhI Europe 2026\, companies can access global supply-chain partners and potential clients from over 150 countries.Exhibitors can showcase APIs\, novel formulations\, or manufacturing services and secure contracts quickly. The integrated zones allow side-by-side comparison of raw-material suppliers\, CDMOs\, and equipment vendors — saving time and increasing deal potential.The new AI & Tech zone offers a prime platform for digital-health and software-solution providers to pitch directly to pharmaceutical decision-makers. This zone aligns with industry shifts toward automation\, regulatory compliance\, data-driven operations\, and manufacturing efficiency.Moreover\, packaging\, cold-chain and logistics providers can meet potential clients actively expanding global distribution networks. \nFinally\, attendees gain access to high-level networking\, matchmaking services and thought-leadership sessions that reflect the latest trends in pharma manufacturing\, supply-chain resilience\, and innovation. \nKey Industries Represented\nCPhI Europe 2026 spans multiple sectors. These include: pharmaceutical manufacturing\, biopharma/biotechnology\, API and excipient supply\, contract manufacturing and development\, drug-delivery systems\, packaging and logistics\, laboratory and processing equipment\, and digital pharma/technology solutions.In addition\, natural-extract suppliers\, fine-chemical producers\, and companies focused on regulatory compliance\, cold-chain logistics\, or cleanroom technologies will find strong representation.
URL:https://ingredientpharm.com/event/cphi-europe-2026/
LOCATION:Fiera Milano\, Strada Statale Sempione\, 28\, Rho MI\, 20017\, Italy
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/CPhI-Europe-2026.jpg
ORGANIZER;CN="informa markets":MAILTO:imdatateam@informa.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260923
DTEND;VALUE=DATE:20260925
DTSTAMP:20260112T144107Z
CREATED:20260112T144107Z
LAST-MODIFIED:20260112T144107Z
UID:2268-1790121600-1790294399@ingredientpharm.com
SUMMARY:Ilmac 2026
DESCRIPTION:Ilmac 2026 will take place on 23–24 September 2026 at the Beaulieu venue in Lausanne\, Switzerland.This event ranks among the most important gatherings for the chemical\, biotech\, laboratory\, and life-science industries in French-speaking Switzerland. \nFocus Areas & Topics\nAt Ilmac\, exhibitors present innovations in laboratory technology\, process engineering\, diagnostics\, bioanalytics\, and biotechnology.The fair also addresses automation\, robotics\, information technology\, safety & environmental solutions\, packaging and pharmaceutical logistics\, and quality control systems.Beyond tech\, Ilmac highlights sustainable practices\, eco-conscious event design\, and circular-economy solutions. \nMoreover\, the 2026 program features a science-driven conference\, startup-showcase area\, expert talks\, and a “Speakers Corner” for pitches. \nTypical Visitors & Key Participants\nAttendees include decision-makers and specialists from chemical companies\, pharmaceutical and biotech firms\, and research labs.Also present are suppliers of lab equipment\, automation and process-engineering vendors\, packaging and logistic providers\, and quality-control service firms.Moreover\, the fair draws startup founders\, R&D scientists\, lab managers\, procurement officers\, and regulatory-compliance experts looking for new solutions or collaborations. \nOutstanding Opportunities\nIlmac 2026 offers companies a chance to present new products and technologies to a highly relevant audience. Exhibitors can generate leads\, secure partnerships\, and engage with regional and international stakeholders.Startups can benefit especially from the dedicated Startup Area and speaker slots — ideal for visibility and early-stage networking.Attendees can compare lab and process technologies side by side\, discover automation and biotech innovations\, and connect with suppliers that match their project needs.Also\, Ilmac’s focus on sustainability and circular solutions gives firms a platform to showcase eco-aware practices — which increasingly appeal to regulators and partners. \nKey Industries Represented\nIlmac 2026 brings together multiple sectors: chemicals\, biotechnology\, pharmaceuticals\, laboratory & analytical technology\, process engineering\, robotics & automation\, environmental & safety technology\, packaging & logistics\, and quality control services. \nIn addition\, the event attracts companies working in diagnostics\, bioanalytics\, biotech start-ups\, contract research/ manufacturing\, and regulatory-compliance consulting — making it a full-spectrum hub for life-sciences innovation.
URL:https://ingredientpharm.com/event/ilmac-2026/
LOCATION:Beaulieu SA\, Av. Bergières 10\, Lausanne\, 1004\, Switzerland
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/ILMAC-2026.jpg
ORGANIZER;CN="MCH Exhibitions & Events GmbH":MAILTO:info@mch-group.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260825
DTEND;VALUE=DATE:20260828
DTSTAMP:20260112T144102Z
CREATED:20260112T144102Z
LAST-MODIFIED:20260112T144102Z
UID:2264-1787616000-1787875199@ingredientpharm.com
SUMMARY:CPhI Korea 2026
DESCRIPTION:CPhI Korea 2026 takes place from 25–27 August 2026 at the COEX Convention & Exhibition Center in Seoul.This event represents one of Asia’s top pharmaceutical trade fairs and invites global pharma\, biotech\, and ingredient players. \nFocus & Topics\nAt CPhI Korea\, attendees explore a full pharma value chain: active pharmaceutical ingredients (APIs)\, excipients\, intermediates\, and finished dosage forms.Moreover\, the fair features biopharmaceuticals\, natural-ingredient health products\, and nutraceutical supplies.Additionally\, machinery\, lab and production equipment\, packaging\, drug-delivery systems\, and GMP-compliant manufacturing services appear.CPhI Korea also offers contract development\, manufacturing\, and outsourcing services\, plus analytical and regulatory support. \nKey Visitors & Participants\nThe fair draws pharmaceutical manufacturers\, API suppliers\, and biopharma developers.R&D experts\, procurement managers\, regulatory and quality-assurance personnel also attend.In addition\, equipment vendors\, packaging experts\, lab-service providers\, contract manufacturers and nutraceutical ingredient suppliers come together under one roof. \nOutstanding Opportunities\nCPhI Korea offers unmatched access to South Korea’s fast-growing pharmaceutical and biotech market.Companies gain a chance to meet hundreds of potential partners\, secure supply agreements\, or find outsourcing solutions — all in few days.Emerging biopharma firms enjoy direct contact with international CDMOs\, regulators\, and global distributors.Moreover\, firms can compare lab technologies\, discuss GMP-compliant manufacturing\, and explore natural-ingredient or nutraceutical market trends. \nKey Industries Represented\nCPhI Korea spans pharmaceutical manufacturing\, biopharmaceuticals\, fine chemicals\, and nutraceuticals.It also covers production and lab equipment\, packaging and drug-delivery systems\, contract manufacturing\, and regulatory services.Thus\, the event reflects the full spectrum of modern pharma and biotech — from raw materials and APIs to finished products\, equipment\, and compliance.
URL:https://ingredientpharm.com/event/cphi-korea-2026/
LOCATION:COEX Convention & Exhibition Center\, 513 Yeongdong-daero\, Seoul\, Gangnam District\, Korea\, Republic of
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/CPhI-Korea-2026.jpg
ORGANIZER;CN="informa markets":MAILTO:imdatateam@informa.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260616
DTEND;VALUE=DATE:20260619
DTSTAMP:20260112T144047Z
CREATED:20260112T144047Z
LAST-MODIFIED:20260112T144047Z
UID:2259-1781568000-1781827199@ingredientpharm.com
SUMMARY:PCI Days 2026
DESCRIPTION:PCI Days 2026 will take place from 16–18 June 2026 at EXPO XXI in Warsaw. This trade fair serves the pharmaceutical\, cosmetics\, and dietary-supplement industries across Poland and Eastern Europe. \nFocus and Themes\nThe fair highlights raw materials\, ingredients\, and packaging solutions for pharma\, cosmetics\, and supplements. It also covers machinery\, production equipment\, laboratory services\, quality assurance\, and logistics. Additionally\, PCI Days offers contract manufacturing services and private-label solutions. \nMoreover\, the event includes thematic zones for machinery\, full-service solutions\, and specialized supply-chain services. Through conferences and workshops\, it delivers up-to-date insights about regulation\, production trends\, and market dynamics. \nKey Visitors & Participants\nPCI Days attracts producers of medicines\, cosmetics\, and dietary supplements. It also draws R&D scientists\, quality-assurance staff\, laboratory technicians\, packaging and production engineers\, procurement managers\, and company executives. Suppliers of raw materials\, packaging\, machinery\, lab services\, private-label & contract manufacturing services also attend. \nBecause the fair brings together such a diverse group\, it enables effective networking and business development. \nOutstanding Opportunities\nPCI Days gives companies direct access to a broad B2B audience across pharma\, cosmetics\, and supplements. Exhibitors can present new ingredients\, technologies\, or services. Manufacturers may secure supply-chain deals\, contract manufacturing\, or private-label production. As attendees come from many segments\, businesses can find cross-industry partners under one roof. \nThe event’s structure — with separate halls for machinery and comprehensive solutions — allows efficient comparison of suppliers\, equipment\, and service providers. Also\, the dedicated networking and conference program helps participants stay updated on regulation\, quality standards\, and industry trends. \nGiven its regional reach across Central and Eastern Europe\, PCI Days opens doors for international cooperation and expansion into new markets. \nKey Industries Represented\nThe main industries present at PCI Days include pharmaceutical manufacturing\, cosmetics production\, dietary supplements\, raw-material supply\, packaging\, production machinery\, laboratory services\, contract manufacturing & private-label\, and logistics & supply-chain solutions. \nThese sectors converge under one roof — enabling holistic collaboration\, innovation sharing\, and business growth.
URL:https://ingredientpharm.com/event/pci-days-2026/
LOCATION:Warsaw EXPO XXI\, Ignacego Prądzyńskiego 12/14\, Warsaw\, 01-222\, Poland
CATEGORIES:consumer health,pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/PCI-Days-2026.jpg
ORGANIZER;CN="Farmacom":MAILTO:redakcja@farmacom.com.pl
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260616
DTEND;VALUE=DATE:20260619
DTSTAMP:20260304T120648Z
CREATED:20260112T144039Z
LAST-MODIFIED:20260304T120648Z
UID:2249-1781568000-1781827199@ingredientpharm.com
SUMMARY:CPhI China 2026
DESCRIPTION:CPhI China 2026 will take place from 16–18 June 2026 at the Shanghai New International Expo Centre (SNIEC) in Shanghai. This event represents Asia’s premier pharmaceutical industry gathering and spans the full pharma value chain. Discover pelletized excipients for oral pharmaceutical formulations at booth E3D16\, Shanghai Shen Mei Pharmaceutical Technology Co.\, Ltd. See: exhibitor list. \nEvent Scope & Purpose\nCPhI China gives companies a single platform to source ingredients\, find partners\, and showcase innovations.It connects global and Chinese pharmaceutical professionals.Attendees can explore APIs\, excipients\, finished dosages\, biopharma\, natural extracts\, and contract services — all under one roof. \nMain Topics & Focus Areas\nThe show highlights active pharmaceutical ingredients (APIs)\, intermediates\, and fine chemicals.It also features excipients\, formulations\, and finished dosage forms.Biopharmaceuticals\, natural extracts\, and contract manufacturing/outsourcing services have strong representation.Further focus includes pharmaceutical machinery\, production technologies\, packaging\, drug‑delivery systems\, lab & cleanroom equipment\, and environmental/processing solutions. \nWho Attends & Key Visitors\nCPhI China draws pharmaceutical manufacturers\, API and raw‑material suppliers\, biopharma developers\, and contract manufacturing organizations (CMOs/CROs).R&D teams\, procurement and supply‑chain managers\, regulatory experts\, and quality assurance professionals also attend.Additionally\, machinery and equipment vendors\, packaging specialists\, and service providers for drug delivery and lab technologies join the event. \nOutstanding Opportunities\nCPhI China offers unmatched access to China’s vast and growing pharmaceutical market.Exhibitors can meet thousands of potential partners and negotiate supply\, outsourcing or contract manufacturing deals.The event also enables newcomers and established firms alike to benchmark technologies\, launch new products\, and align with evolving regulatory and industry standards. \nIndustries Represented\nCPhI China spans the chemical‑pharmaceutical industry\, biopharma\, fine chemicals\, natural‑extracts supply\, contract manufacturing\, and pharma outsourcing services.It also includes sectors connected to equipment\, production technology\, packaging & drug delivery\, laboratory instruments\, clean‑room systems\, and quality control.
URL:https://ingredientpharm.com/event/cphi-china-2026/
LOCATION:Shanghai New International Expo Center\, 龙阳路2345号\, Shanghai\, 201204\, China
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/CPhI-China-2026.jpg
ORGANIZER;CN="informa markets":MAILTO:imdatateam@informa.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260514
DTSTAMP:20260112T144027Z
CREATED:20260112T144027Z
LAST-MODIFIED:20260112T144027Z
UID:2240-1778457600-1778716799@ingredientpharm.com
SUMMARY:CPhI Middle East 2026
DESCRIPTION:CPhI Middle East 2026\, held in Riyadh\, is the region’s leading pharmaceutical trade fair and global industry hub. The next edition is scheduled for May 11–13\, 2026\, at the Riyadh Exhibition and Convention Centre in Malham. \nAt CPhI Middle East 2026\, the exhibition spans the entire pharmaceutical value chain. Specifically\, it showcases APIs\, excipients\, fine chemicals\, natural extracts\, and finished dosage forms. Additionally\, it features contract services\, biotechnology\, pharma machinery\, packaging\, drug delivery systems\, and processing technologies. \nThe event attracts a diverse\, high-level visitor profile from across the pharmaceutical ecosystem. Notably\, attendees include senior executives\, decision-makers\, regulators\, procurement leaders\, and R&D\, manufacturing\, and business development heads. Furthermore\, it serves companies seeking to establish or expand operations in the MENA region. \nCPhI Middle East 2026 provides strong opportunities for strategic partnerships between global suppliers and regional manufacturers. Moreover\, it enables direct access to Saudi Arabia’s rapidly expanding pharmaceutical market. Consequently\, participants can also reach broader MENA demand through one central platform. With growing local manufacturing\, supported by regulatory incentives\, the event becomes an ideal sourcing venue. \nKey industries represented include pharma manufacturing\, biotechnology\, contract services\, ingredients\, equipment\, packaging\, and drug-delivery solutions. Finally\, the exhibition reflects regional priorities: local production growth\, biologics innovation\, and increasing pharma supply-chain self-sufficiency.
URL:https://ingredientpharm.com/event/cphi-middle-east-2026/
LOCATION:Riyadh Exhibition & Convention Center\, 792P+JQ\, Malham\, 13380\, Saudi Arabia
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/CPhI-Middle-East-2026.jpeg
ORGANIZER;CN="informa markets":MAILTO:imdatateam@informa.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260421
DTEND;VALUE=DATE:20260423
DTSTAMP:20260112T144009Z
CREATED:20260112T144009Z
LAST-MODIFIED:20260112T144009Z
UID:2171-1776729600-1776902399@ingredientpharm.com
SUMMARY:Making Pharmaceuticals\, Making Nutraceuticals
DESCRIPTION:Making Pharmaceuticals\, Making Nutraceuticals 2026 is a leading UK conference and exhibition held on 21–22 April 2026 at the Coventry Building Society Arena. This event gathers pharmaceutical and nutraceutical professionals for free access to exhibits\, conferences\, and networking. Attendees can explore all three programmes—Making Pharmaceuticals\, Distributing Pharmaceuticals\, and Making Nutraceuticals—with a single registration. \nThe conference offers focused sessions on formulation\, regulatory compliance\, manufacturing\, sustainability\, packaging\, distribution\, functional ingredients\, and quality assurance. Additionally\, a theatre dedicated to APIs provides insights into sourcing\, trends\, and cross-industry applications. \nMore than 150 exhibitors showcase equipment\, materials\, services\, logistics\, compliance solutions\, and ingredients. Attendees can quickly find solutions for production\, supply chains\, and regulatory needs. Exhibitors include multinational brands\, niche innovators\, and service specialists\, creating a strong business marketplace. Among the exhibitions\, HARKE Pharma will present pelletized excipients and actives\, such as CELLETS®\, TAP® and Ibuprofen DC100. \nVisitor numbers show growing influence\, with over 1\,700 professionals attending recent editions. The audience includes formulation scientists\, regulatory leaders\, manufacturing directors\, distribution executives\, and product developers. The event promotes collaboration as pharmaceutical and nutraceutical sectors increasingly overlap. \nKey opportunities include targeted networking\, sponsorship exposure\, and direct engagement with industry decision-makers. Furthermore\, the Excellence Awards recognize innovation and sustainability in product development\, manufacturing\, and distribution. All eligible participants can enter the awards. \nIn conclusion\, Making Pharmaceuticals\, Making Nutraceuticals 2026 offers learning\, discovery\, and collaboration opportunities. It supports innovation\, operational excellence\, and growth across health science industries.
URL:https://ingredientpharm.com/event/making-pharmaceuticals-making-nutraceuticals/
LOCATION:Coventry Building Society Arena\, Judds Ln\, Coventry\, CV6 6GE\, United Kingdom
CATEGORIES:consumer health,pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2026/01/Making-Nutraceuticals.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260331
DTEND;VALUE=DATE:20260403
DTSTAMP:20260112T143941Z
CREATED:20260112T143941Z
LAST-MODIFIED:20260112T143941Z
UID:2205-1774915200-1775174399@ingredientpharm.com
SUMMARY:World Vaccine Congress in Washington 2026
DESCRIPTION:The World Vaccine Congress in Washington 2026 stands among the most influential global events for vaccines and immunotherapy innovation. Each year in Washington\, D.C.\, it convenes leaders from science\, industry\, regulation\, public health\, and investment. Together\, participants address critical challenges and breakthroughs in vaccine research\, development\, and manufacturing. As the world’s largest vaccine-focused meeting\, it represents a key milestone across the global vaccine ecosystem. \nIn 2026\, the congress will again examine the full spectrum of vaccine science and technology. Specifically\, sessions span basic immunology\, antigen discovery\, clinical development\, regulatory science\, and manufacturing scale-up. Moreover\, the agenda features mRNA platforms\, viral vectors\, recombinant vaccines\, adjuvants\, AI-driven research\, and pandemic preparedness. In addition\, discussions cover global health policy\, supply-chain resilience\, therapeutic vaccines\, and next-generation production tools. \nAttendees include vaccine developers\, pharmaceutical manufacturers\, biotech innovators\, and academic researchers. Likewise\, epidemiologists\, policymakers\, investors\, NGOs\, and global health organizations actively participate. Government agencies such as the FDA\, NIH\, BARDA\, and CDC also play a central role. Consequently\, the congress aligns scientific progress\, regulatory strategy\, and commercial decision-making. \nFurthermore\, the World Vaccine Congress in Washington 2026 delivers exceptional networking and business development opportunities. Companies showcase emerging technologies\, explore partnerships\, and gain insight into global regulatory expectations. Meanwhile\, researchers access cutting-edge data\, while policymakers examine frameworks to strengthen immunization and preparedness. Therefore\, the event strongly benefits organizations across biotechnology\, pharmaceuticals\, diagnostics\, AI\, and supply-chain solutions. \nSPI Pharma\, a global leader in vaccine adjuvants\, excipients\, and drug delivery solutions\, accelerates vaccine innovation worldwide. At the congress\, SPI Pharma will present its portfolio on adjuvant technologies to support stronger immune responses and scalable vaccine development. Do not forget talking on ACTILLETS™ (SPI branded CELLETS®) or TAP®\, both pelletized excipients made for modern pharmaceutical formulations. Additionally\, company experts will discuss advanced adjuvant systems developed with partners to expand accessible\, effective vaccine options. Through these contributions\, SPI Pharma aims to strengthen vaccine design and global immunization impact at WVC 2026. \nBy uniting leading vaccine and immunotherapy experts\, the 2026 congress accelerates innovation and advances global health strategies. As a result\, it will help shape the next generation of vaccines worldwide.
URL:https://ingredientpharm.com/event/world-vaccine-congress-in-washington-2026/
LOCATION:Walter E. Washington Convention Center\, 801 Allen Y. Lew Place NW\, Washington DC\, DC\, 20001\, United States
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/World-Vaccine-Congress-Washington.jpg
ORGANIZER;CN="Terrapinn Holdings Ltd":MAILTO:enquiry.uk@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260329
DTEND;VALUE=DATE:20260401
DTSTAMP:20260211T090602Z
CREATED:20260112T143916Z
LAST-MODIFIED:20260211T090602Z
UID:2189-1774742400-1775001599@ingredientpharm.com
SUMMARY:Asia Pharma Expo Dhaka
DESCRIPTION:Asia Pharma Expo (APE)\, launched in 2003\, has become one of South Asia’s most important pharmaceutical industry platforms. Consequently\, its name reflects Asia’s diverse\, fast-growing\, and strategically vital pharmaceutical market globally. \nHeld annually at the Bangladesh–China Friendship Exhibition Center (BCFEC) in Dhaka\, the expo attracts both regional and global stakeholders. Therefore\, this location highlights Bangladesh’s growing pharmaceutical influence and reinforces Dhaka as a major South Asian commercial hub. \nOrganized by GPE Expo Pvt. Ltd.\, a leading international trade fair specialist\, Asia Pharma Expo unites local and global exhibitors\, professionals\, and decision-makers. Each year\, it showcases innovations\, technologies\, and services shaping the pharmaceutical future. \nThe expo spans pharmaceuticals\, nutraceuticals\, biotechnology\, cosmetics\, and healthcare solutions. Key features include processing machinery\, APIs\, bulk drug intermediates\, excipients\, cleanroom technologies\, water treatment\, and integrated management systems. As a result\, it serves as a dynamic networking hub for knowledge exchange\, partnerships\, and business discovery. \nExhibitors include pharmaceutical manufacturers\, biotech firms\, medical technology producers\, and service providers. Meanwhile\, visitors include CEOs\, senior executives\, R&D\, quality assurance\, production\, and procurement professionals\, making it ideal for high-level business interactions. \nRelated Topics\n\nPharmaceutical Excipients\nPharmaceutical Packaging Machinery\nPharmaceutical Ingredients Suppliers\nPharma Contract Manufacturing\nCleanroom Equipment Dhaka\n\nThe BCFEC offers a modern\, well-equipped venue with excellent transport links\, convenient for domestic and international participants. Moreover\, Dhaka combines cultural heritage with rapid industrial growth\, increasing the event’s appeal. \nAsia Pharma Expo 2026 will run three days\, from 29 March to 31 March 2026\, in Purbachal\, Dhaka\, Bangladesh.
URL:https://ingredientpharm.com/event/asia-pharma-expo-dhaka/
LOCATION:Bangladesh-China Friendship Exhibition Center\, Purbachal New Town Project\, Dhaka\, RGVM+6R\, Bangladesh
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/Asia-Pharma-Expo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260327
DTSTAMP:20260304T160608Z
CREATED:20260112T143934Z
LAST-MODIFIED:20260304T160608Z
UID:2194-1774224000-1774569599@ingredientpharm.com
SUMMARY:DCAT Week 2026
DESCRIPTION:DCAT Week 2026 is a leading global meeting for the pharmaceutical manufacturing value chain. Organized by DCAT\, it occurs in New York City each March. Senior executives from pharma companies and key development\, manufacturing\, sourcing\, and supply partners meet there for interdisciplinary exchange. \n\nLet’s talk on CDMO solutions and clinical supplies during DCAT: Book time to meet with Philippe \n\nDCAT Week facilitates strategic meetings among innovator pharma\, generic manufacturers\, contract service providers\, technology developers\, and suppliers. In 2026\, the event will let industry leaders discuss market trends\, form partnerships\, negotiate supply agreements\, and explore emerging technologies shaping drug development and commercialization. \nThe event covers topics like global supply chains\, advanced manufacturing\, sourcing strategies\, drug substance and product innovation\, biologics\, cell and gene therapies\, sustainability\, digital transformation\, regulatory updates\, and portfolio management. These subjects appear in keynotes\, educational programs\, networking events\, and private business meetings across Midtown Manhattan. \nSPI Pharma will inform on starter spheres for extended release formulation designs \nAttendees include C-suite executives\, procurement directors\, supply-chain strategists\, R&D and technical leaders\, business development managers\, and regulatory specialists from major pharma companies\, CDMOs\, CMOs\, API manufacturers\, excipient suppliers\, technology providers\, packaging firms\, and logistics companies. This exclusive environment enables meaningful interactions\, making it one of the industry’s most valuable annual gatherings. \nDCAT 2026 offers companies opportunities to strengthen global partnerships\, increase visibility among top buyers. Also take the chance to understand market dynamics\, and identify innovations that improve manufacturing and supply reliability. Its concentration of industry leaders in one city creates an unmatched platform for strategic collaboration and competitive intelligence.
URL:https://ingredientpharm.com/event/dcat-week-2026/
LOCATION:New York Hilton Midtown Grand Ballroom\, 1335 6th Ave\, New York\, NY\, 10019\, United States
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/DCAT-2026.jpeg
ORGANIZER;CN="DCAT Global Headquarters":MAILTO:info@dcat.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260327
DTSTAMP:20260304T160947Z
CREATED:20260112T103655Z
LAST-MODIFIED:20260304T160947Z
UID:2199-1774224000-1774569599@ingredientpharm.com
SUMMARY:15th PBP World Meeting on Pharmaceutics\, Biopharmaceutics and Pharmaceutical Technology
DESCRIPTION:15th PBP World Meeting will take place in Prague/CZ in March 23-26\, 2026 and will continue its strong international reputation. The conference ranks among the most respected scientific meetings in pharmaceutical science. Moreover\, it operates under the Pharmaceutical Technology platform with support from leading academic and industry partners. As a result\, it serves as a key global forum for advanced research in drug development and formulation science. \nThe 15th PBP World Meeting brings together innovation\, applied research\, and regulatory perspectives. Therefore\, it supports knowledge exchange at a high scientific level. In addition\, it strengthens collaboration between academia and industry. \nScientific Focus of the 15th PBP World Meeting\nPBP focuses on current advances in pharmaceutics and biopharmaceutics. In particular\, it addresses novel drug delivery systems and modern formulation technologies. Moreover\, the scientific program explores predictive modeling\, continuous manufacturing\, and nanomedicine. \nIn addition\, sessions examine regulatory-science integration and its growing role in development strategies. Therefore\, participants gain practical insight into evolving approval expectations. The program also covers pharmaceutical 3D printing\, personalized medicine\, innovative excipients\, and quality-by-design strategies. Furthermore\, advanced analytical methods receive strong attention as enablers of efficient product development. \nThe conference emphasizes research quality and scientific depth. As a result\, oral sessions and poster presentations highlight how innovation shapes future pharmaceutical manufacturing. \nParticipants and Collaboration Opportunities\nThe 15th PBP World Meeting attracts a highly specialized international audience. It welcomes academic researchers\, formulation scientists\, biopharmaceutical experts\, and R&D managers. In addition\, regulatory professionals and technology developers attend from pharmaceutical and biotechnology companies. \nTherefore\, the meeting creates a productive environment for scientific exchange. Moreover\, it encourages direct interaction between research institutions and industry leaders. Participants can build partnerships for development projects and technology transfer. As a result\, collaboration extends beyond the conference itself. \nThe World Meeting also supports companies that seek scientific visibility. Consequently\, organizations involved in excipients\, analytical technologies\, drug delivery systems\, and manufacturing equipment benefit from targeted engagement. \nIndustry Scope and Location Advantage\nIndustries represented at the 15th PBP World Meeting include pharmaceuticals\, biotechnology\, analytical instrumentation\, and advanced manufacturing. In addition\, research organizations focused on formulation science and therapeutic innovation play a central role. \nPrague offers strong advantages as the host city. Moreover\, it provides excellent international accessibility and a rich scientific tradition. Therefore\, the location enhances both attendance and collaboration. \nIn conclusion\, the 15th PBP World Meeting delivers high scientific value\, strong networking potential\, and clear industry relevance. As a result\, it remains an essential event for professionals in pharmaceutical science and technology.
URL:https://ingredientpharm.com/event/15th-pbp-world-meeting-on-pharmaceutics-biopharmaceutics-and-pharmaceutical-technology/
LOCATION:Holiday Inn Prague Congress Centre\, Na Pankráci 1684/ 15\, Praha\, 140 00\, Czech Republic
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/PBP-2026.jpeg
ORGANIZER;CN="Arbeitsgemeinschaft f%C3%BCr Pharmazeutische Verfahrenstechnik e. V. (APV)":MAILTO:info@apv-mainz.de
END:VEVENT
END:VCALENDAR